SCHEMBL9818422

SCHEMBL9818422

Oc1ccc(SCc2ccc3ccccc3n2)cc1S

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 1/20 0.42
CYSLTR1 Q9Y271 1/20 0.42
RXFP1 Q9HBX9 3/20 0.40
PRNP P04156 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2E1 P05181 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 3/20 0.39
MAPK10 P53779 1/20 0.39
PDE10A Q9Y233 1/20 0.39
RAB9A P51151 1/20 0.38
MEN1 O00255 3/20 0.38
GAA P10253 3/20 0.38
KMT2A Q03164 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456253 0.80 CYSLTR1 (0.49) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
SCHEMBL7455761 0.80 CYSLTR2 (0.49) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
SCHEMBL7714637 0.79 CYSLTR1 (0.43) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
SCHEMBL7460680 0.79 CYP1A2 (0.43) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
Hydrogen Sulfide SCHEMBL9818421 0.79 CYSLTR1 (0.48) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
SCHEMBL10546745 0.76 CYSLTR2 (0.50) CYSLTR2CYSLTR1RXFP1PRNPKDM4E
SCHEMBL5373500 0.74 CYSLTR2 (0.49) CYSLTR2CYSLTR1KDM4ECYP1A2CYP2E1
SCHEMBL9818433 0.73 PDE10A (0.63) CYSLTR2CYSLTR1PDE10AGPBAR1
SCHEMBL6641172 0.70 RAB9A (0.47) RXFP1PRNPKDM4ECYP1A2CYP2E1
SCHEMBL13058918 0.70 SMN1; SMN2 (0.45) RXFP1PRNPKDM4ECYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5059610-A QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-10-22 US disclosed